These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2526246)

  • 41. [Mycoplasma pneumoniae infection and drug resistance in children: an analysis of 1026 cases].
    Yang AM; Song JH; Huang R; Jin SJ; Yang P
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Jul; 15(7):522-5. PubMed ID: 23866271
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Bacteriological, pharmacokinetic and clinical evaluation of azithromycin in the pediatric field].
    Akita H; Sato Y; Kusumoto Y; Iwata S; Takeuchi Y; Aoyama T; Yokota T; Sunakawa K
    Jpn J Antibiot; 1996 Oct; 49(10):899-916. PubMed ID: 8986553
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clarithromyocin new approaches to the treatment of respiratory tract infection. Seventh Mediterranean Congress of Chemotherapy. Barcelona, Spain, May 1990.
    J Antimicrob Chemother; 1991 Feb; 27 Suppl A():1-124. PubMed ID: 1827093
    [No Abstract]   [Full Text] [Related]  

  • 44. An open, randomized, comparative study of clarithromycin and erythromycin in the treatment of children with community-acquired pneumonia.
    Lee PI; Wu MH; Huang LM; Chen JM; Lee CY
    J Microbiol Immunol Infect; 2008 Feb; 41(1):54-61. PubMed ID: 18327427
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Single oral dose of azithromycin versus 5 days of oral erythromycin or no antibiotic in treatment of campylobacter enterocolitis in children: a prospective randomized assessor-blind study.
    Vukelic D; Trkulja V; Salkovic-Petrisic M
    J Pediatr Gastroenterol Nutr; 2010 Apr; 50(4):404-10. PubMed ID: 19881393
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The erythromycins. A further report from the Australian Drug Evaluation Committee.
    Med J Aust; 1973 Jul; 2(4):192-3. PubMed ID: 4741351
    [No Abstract]   [Full Text] [Related]  

  • 47. [Penetration of clarithromycin to saliva and its effect on normal salivary bacterial flora].
    Morihana T; Kaneko A; Tomita F; Suwa T; Kohno Y; Kobayashi I
    Jpn J Antibiot; 1989 Apr; 42(4):973-82. PubMed ID: 2528003
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics].
    Akita H; Sato Y; Iwata S; Sunakawa K
    Jpn J Antibiot; 1989 Jul; 42(7):1547-60. PubMed ID: 2810729
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Use of erythromycin administered rectally in children. Controlled study].
    Crosato M; Cattaneo G
    Minerva Pediatr; 1978 Jan; 30(1):79-87. PubMed ID: 345076
    [No Abstract]   [Full Text] [Related]  

  • 50. [Microbiological, pharmacokinetic and clinical studies of rokitamycin dry syrup in the pediatric field].
    Motohiro T; Aramaki M; Oda K; Kawakami A; Tanaka K; Koga T; Fujimoto T; Sakata Y; Yamashita F; Suzuki K
    Jpn J Antibiot; 1988 Jul; 41(7):920-59. PubMed ID: 3050186
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and tolerability of clarithromycin administered to children at higher-than-recommended doses.
    Kafetzis DA; Chantzi F; Tigani G; Skevaki CL
    Eur J Clin Microbiol Infect Dis; 2007 Feb; 26(2):99-103. PubMed ID: 17216420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Meta-analysis of clarithromycin compared to other antibiotics for the treatment of lower respiratory tract infections].
    Gálvez-Múgica MA; Espinosa de los Monteros MJ; Gallego Sandín S; Novalbos J; Abad-Santos F
    Rev Esp Quimioter; 2003 Dec; 16(4):403-11. PubMed ID: 14961134
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of dosing intervals on efficacy of clarithromycin and erythromycin in mouse infection models.
    Fernandes PB; Swanson RN; Hardy DJ; McDonald EJ; Ramer N
    Drugs Exp Clin Res; 1988; 14(7):441-4. PubMed ID: 2977115
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical studies of cefoperazone in pediatric field (author's transl)].
    Aoyama R; Kuronuma T; Nagata K; Izumi Y
    Jpn J Antibiot; 1980 Aug; 33(8):799-802. PubMed ID: 6451727
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Erythromycin-sulfas in pediatric practice: efficacy and patient acceptance.
    Chisholm WS
    Ariz Med; 1968 Aug; 25(8):707-9. PubMed ID: 5674274
    [No Abstract]   [Full Text] [Related]  

  • 56. Clarithromycin in the treatment of bacterial relapses of chronic bronchitis.
    Dericoloso A; Sanduzzi A; Cuccurullo S; Sarno M; Bianco A; Moro RA
    Riv Eur Sci Med Farmacol; 1991; 13(5-6):275-83. PubMed ID: 1840282
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Laboratory and clinical studies on cefodizime in the pediatric field].
    Yanagishima M; Yanai M; Yanagi T; Tsuji Y; Imamura H; Nakayama N
    Jpn J Antibiot; 1989 Jun; 42(6):1424-35. PubMed ID: 2795866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [A new macrolide antibiotic--Azithromycin in the therapy of respiratory infections].
    Music E; Kumelj M; Rus A
    Plucne Bolesti; 1988; 40(3-4):137-9. PubMed ID: 2855273
    [No Abstract]   [Full Text] [Related]  

  • 59. [Laboratory and clinical studies of cefodizime in pediatric field].
    Nakao Y; Takeuchi H; Kimura H; Ishikawa H; Hayakawa F; Kuno K
    Jpn J Antibiot; 1989 Jun; 42(6):1336-45. PubMed ID: 2795857
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Experiences with erythromycin in infant infections, especially respiratory tract infections].
    Sander C
    Klin Padiatr; 1972 Jan; 184(1):55-8. PubMed ID: 4402000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.